Report
Rob Hales
EUR 850.00 For Business Accounts Only

Morningstar | No Surprises in Johnson Matthey’s 1Q Trading Update

Narrow-moat Johnson Matthey provided a trading update for the first quarter, but didn't report any numbers. The company stated that first-quarter sales were in line with expectations and guidance for the year was unchanged. We don’t see anything in the commentary that conflicts with our current view. Consequently, we don’t expect to change our GBX 3,050 fair value estimate, other than to account for the time value of money. At current levels, the shares look overvalued.

Clean air was reported to have had a strong start to the year, particularly in light-duty Europe and Asia, while heavy-duty continued to benefit from high production levels for class 8 trucks in North America. Accordingly, we remain comfortable with our expectations for a mid-single-digit sales increase in the division for the year, although an ongoing strong market in class 8 trucks could lead to some upside in our profit forecast.

Efficient natural resources had good growth in catalyst technologies, particularly methanol catalysts. Restructuring and efficiency initiatives are still expected to begin positively affecting the segment in second-half fiscal 2019. We still expect low-single-digit growth in operating profit for the year, which is broadly in line with guidance.

Health sales were stable, as a decline in the generics business was offset by increased sales in the innovators business. Lower profits are expected in the first half of the year but we see profits turning positive by the end of fiscal 2019.
Underlying
Johnson Matthey Plc

Johnson Matthey is a provider of sustainable technologies. Co. operates in five divisions: Emission Control Technologies, a manufacturer of catalysts and catalyst systems that enable clean air; Process Technologies, a supplier of catalysts, licensing technologies and other services to the syngas, oleo/biochemical, petrochemical, oil refining and gas processing industries; Precious Metal Products, which include management, distribution, refining and recycling of precious metals, and fabricate products; Fine Chemicals, a supplier of active pharmaceutical ingredients and custom services for pharmaceutical customers; and New Business, which focuses on additional areas of potential growth.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Rob Hales

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch